(Q46615562)

23 December 2017

title

Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor (English)

1 reference

23 December 2017

author name string

Kemal Sarica

1

1 reference

23 December 2017

Ersin Akarsu

2

1 reference

23 December 2017

Sakip Erturhan

3

1 reference

23 December 2017

Faruk Yagci

4

1 reference

23 December 2017

Sebnem Aktaran

5

1 reference

23 December 2017

Bulent Altay

6

1 reference

23 December 2017

publication date

24 April 2008

1 reference

23 December 2017

published in

Obesity

1 reference

23 December 2017

volume

16

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1579-1584

1 reference

23 December 2017

Hyperoxaluric calcium nephrolithiasis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

The impact of dietary oxalate on kidney stone formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Dietary risk factors for hyperoxaluria in calcium oxalate stone formers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Stones from bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

The role of overweight and obesity in calcium oxalate stone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Impact of body weight on urinary electrolytes in urinary stone formers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Risk formulas in calcium oxalate urolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Contribution of dietary oxalate to urinary oxalate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.244

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.244

1 reference

23 December 2017

PubMed ID

18451780

1 reference

23 December 2017